口腔癌多重原发性瘤:患者特征和生存模式
Journal (Canadian Dental Association)
|June 24, 2025
概括
多重原发性瘤 (MPT) 显著降低了口腔癌患者的存活率. 高龄,并发症和延迟治疗是MPT发展的关键风险因素,需要主动管理.
科学领域:
- 在瘤学瘤学.
- 癌症流行病学 癌症流行病学
背景情况:
- 多重原发性瘤 (MPT) 是口腔癌患者死亡的重要原因.
- 识别MPT的风险因素及其对生存的影响对于患者的治疗结果至关重要.
研究的目的:
- 确定与口腔癌患者MPT发展相关的风险因素.
- 评估MPT发展对口腔癌患者生存率的影响.
主要方法:
- 基于人口的回顾性队列研究,使用来自阿尔伯塔癌症注册表 (2005-2020) 的数据.
- 分析了3549名被诊断为初级口腔癌 (POC) 的患者.
主要成果:
- 总的MPT发生率为14.5% (513名患者).
- 患MPT的危险因素包括老年,低收入和并发症 (COPD,糖尿病,心血管疾病).
- MPT的发展导致生存率急剧下降;晚年,低BMI,同步瘤,晚期POC和多种并发症与生存率低下有关.
结论:
- MPT显著影响口腔癌患者的生存率.
- 高龄,并发症和延迟治疗是MPT的关键风险因素.
- 早期检测和主动管理对于改善存活率至关重要,特别是在高风险患者中.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell
13.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K


